These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 609191

  • 21. Relationship between plasma catecholamines and the renin-aldosterone system during exercise in normal and essential hypertensive subjects.
    Jindra A, Savliková J, Bultas J.
    Clin Exp Hypertens A; 1990; 12(3):415-35. PubMed ID: 2192824
    [Abstract] [Full Text] [Related]

  • 22. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension.
    Sullivan PA, Kelleher M, Twomey M, Dineen M.
    J Hypertens; 1985 Aug; 3(4):359-63. PubMed ID: 2995484
    [Abstract] [Full Text] [Related]

  • 23. Renin-angiotensin-aldosterone system in diabetes mellitus.
    Christlieb AR.
    Diabetes; 1976 Aug; 25(2 SUPPL):820-5. PubMed ID: 823063
    [Abstract] [Full Text] [Related]

  • 24. Low plasma aldosterone despite normal plasma renin activity in uncomplicated type 1 diabetes mellitus: effects of RAAS stimulation.
    Luik PT, Kerstens MN, Hoogenberg K, Navis GJ, Dullaart RP.
    Eur J Clin Invest; 2003 Sep; 33(9):787-93. PubMed ID: 12925038
    [Abstract] [Full Text] [Related]

  • 25. Renin and aldosterone in hypothyroidism: relation to excretion of sodium and potassium.
    Saruta T, Kitajima W, Hayashi M, Kato E, Matsuki S.
    Clin Endocrinol (Oxf); 1980 May; 12(5):483-9. PubMed ID: 7000394
    [Abstract] [Full Text] [Related]

  • 26. Elevated plasma catecholamines in hypertensives with primary glomerular diseases.
    Ishii M, Ikeda T, Takagi M, Sugimoto T, Atarashi K, Igari T, Uehara Y, Matsuoka H, Hirata Y, Kimura K, Takeda T, Murao S.
    Hypertension; 1983 May; 5(4):545-51. PubMed ID: 6345363
    [Abstract] [Full Text] [Related]

  • 27. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T, Endo A, Kato M, Kato T, Ahmmed GU, Omodani H, Osaki S, Ogino K, Hisatome I, Miyakoda H, Fujimoto Y, Yoshida A, Shigemasa C.
    Cardiology; 1997 May; 88(3):238-45. PubMed ID: 9129844
    [Abstract] [Full Text] [Related]

  • 28. Hyporeninemia and hypoaldosteronism in diabetes mellitus.
    Perez GO, Lespier L, Jacobi J, Oster JR, Katz FH, Vaamonde CA, Fishman LM.
    Arch Intern Med; 1977 Jul; 137(7):852-5. PubMed ID: 879919
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Diabetic control and the renin-angiotensin system, catecholamines, and blood pressure.
    Ferriss JB, O'Hare JA, Kelleher CC, Sullivan PA, Cole MM, Ross HF, O'Sullivan DJ.
    Hypertension; 1985 Jul; 7(6 Pt 2):II58-63. PubMed ID: 3935582
    [Abstract] [Full Text] [Related]

  • 31. Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading.
    Williams GH, Cain JP, Dluhy RG, Underwood RH.
    J Clin Invest; 1972 Jul; 51(7):1731-42. PubMed ID: 4338121
    [Abstract] [Full Text] [Related]

  • 32. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
    Kigoshi T, Iwasaki R, Kaneko M, Nakano S, Azukizawa S, Uchida K, Morimoto S.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Changes in blood pressure and in vasoactive and volume regulatory hormones during semistarvation in obese subjects.
    Messaoudi L, Donckier J, Stoffel M, Ketelslegers JM, Kolanowski J.
    Metabolism; 1998 May; 47(5):592-7. PubMed ID: 9591752
    [Abstract] [Full Text] [Related]

  • 36. Relationships between sodium clearance, plasma renin activity, plasma aldosterone, renal hemodynamics and blood pressure in essential hypertension.
    Reubi FC, Weidmann P.
    Clin Exp Hypertens (1978); 1980 May; 2(3-4):593-612. PubMed ID: 7000463
    [Abstract] [Full Text] [Related]

  • 37. Responsiveness of plasma aldosterone: dependency upon basal secretory activity.
    Messerli FH, Weidmann P, DeChâtel R, Maxwell MH.
    Klin Wochenschr; 1978 Jul 15; 56(14):719-26. PubMed ID: 209245
    [Abstract] [Full Text] [Related]

  • 38. Renin-aldosterone responsiveness in uncomplicated juvenile-type diabetes mellitus.
    Moss S, Oster JR, Perez GO, Katz FH, Vaamonde CA.
    Horm Res; 1978 Jul 15; 9(3):130-6. PubMed ID: 640577
    [Abstract] [Full Text] [Related]

  • 39. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients.
    Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M.
    N Engl J Med; 1981 Apr 16; 304(16):930-3. PubMed ID: 7010165
    [Abstract] [Full Text] [Related]

  • 40. Blood pressure regulation, peripheral renin activity and aldosterone in patients with pyelonephritic renal scarring.
    Jacobson SH.
    Acta Physiol Scand; 1987 Oct 16; 131(2):242-8. PubMed ID: 3314352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.